LOGIN  |  REGISTER
Astria Therapeutics

Recent Insider Transactions - Greenwich LifeSciences (NASDAQ: GLSI)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ GLSI Greenwich LifeSciences
Patel Snehal / director, 10 percent owner, officer: CEO and CFO
01/07/2025
Buy
$13.75
1,800
$25K
5.55M
NASDAQ GLSI Greenwich LifeSciences
Patel Snehal / director, 10 percent owner, officer: CEO and CFO
01/06/2025
Buy
$13.31
1,100
$15K
5.55M
NASDAQ GLSI Greenwich LifeSciences
Patel Snehal / director, 10 percent owner, officer: CEO and CFO
01/03/2025
Buy
$12.95
3,400
$44K
5.55M
NASDAQ GLSI Greenwich LifeSciences
Patel Snehal / director, 10 percent owner, officer: CEO and CFO
01/02/2025
Buy
$11.97
2,000
$24K
5.54M
NASDAQ GLSI Greenwich LifeSciences
Patel Snehal / director, 10 percent owner, officer: CEO and CFO
12/31/2024
Buy
$11.36
2,400
$27K
5.54M
NASDAQ GLSI Greenwich LifeSciences
Patel Snehal / director, 10 percent owner, officer: CEO and CFO
12/30/2024
Buy
$11.12
3,200
$36K
5.54M
NASDAQ GLSI Greenwich LifeSciences
Daugherty Frank Joseph / director, officer: Chief Medical Officer
12/24/2024
Buy
$12.16
104,890
$1.275M
209,780
NASDAQ GLSI Greenwich LifeSciences
Hallock Kenneth / director
12/24/2024
Buy
$12.16
41,349
$503K
82,698
NASDAQ GLSI Greenwich LifeSciences
Patel Snehal / director, 10 percent owner, officer: CEO and CFO
12/24/2024
Buy
$12.16
25,008
$304K
2.25M
NASDAQ GLSI Greenwich LifeSciences
Patel Snehal / director, 10 percent owner, officer: CEO and CFO
12/24/2024
Buy
$12.16
1.15M
$13.968M
2.22M
NASDAQ GLSI Greenwich LifeSciences
Rothe Eric / director
12/24/2024
Buy
$12.16
41,349
$503K
82,698
NASDAQ GLSI Greenwich LifeSciences
Thompson Jaye / officer: VP Clinical Reg Affairs
12/24/2024
Buy
$12.16
149,818
$1.822M
299,636
NASDAQ GLSI Greenwich LifeSciences
McWilliams David / director
12/24/2024
Buy
$12.16
61,984
$754K
123,968
NASDAQ GLSI Greenwich LifeSciences
Thompson Jaye / officer: VP Clinical Reg Affairs
11/21/2024
Buy
$12.91
1,000
$13K
264,148